Announcements Trials
Browse Landscape

Phase

Phase NA 57Phase 4 25Phase 3 8Phase 2/3 8Phase 2 5Phase 1/2 1

Status

Unknown 2Completed 2Withdrawn 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Other 2Endocrine 2Other neoplasm 1

Conditions

Pheochromocytoma 1Pain, Intractable 1Obesity 1Non-functioning Pituitary Adenoma 1Neoplasms 1Nausea 1Intrathecal Dexmedetomidine 1Dyspnea 1Delirium 1Death 1

Interventions

Cisplatin 1519Carboplatin 1420Cyclophosphamide 1360Gemcitabine 1235Bevacizumab 1226Paclitaxel 1211Radiotherapy 1176Docetaxel 1080pembrolizumab 1028Oxaliplatin 936Capecitabine 901Fluorouracil 833Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 666Etoposide 660Irinotecan 622Leucovorin 575Pemetrexed 510Drug Therapy 493Cetuximab 483Trastuzumab 469Cytarabine 466Magnetic Resonance Spectroscopy 458Filgrastim 446Prednisone 433Lenalidomide 409Specimen Handling 408Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Interventional × Dexmedetomidine × Clear all
NCT04730375 2022-05-05

Evaluation of the Effect of Different Doses Dexmedetomidine Infusion on Lung Mechanics and Oxygenation in Obese Patients

National Cancer Institute, Egypt

Phase 2 Completed
70 enrolled
Other

Obesity

NCT04320589 2021-09-01

the Effect of Dexmedetomidine and Magnesium Sulfate in Open Resection of Pheochromocytoma

National Cancer Institute, Egypt

Phase 2 Completed
30 enrolled
Endocrine

Pheochromocytoma

NCT05005715 2021-08-13

Effect of Dexmedetomidine on Quality of Recovery in Non-functioning Pituitary Adenoma Patients Undergoing Endoscopic Transsphenoidal Surgery

Seoul National University Hospital

Phase 2 Unknown
64 enrolled
Endocrine

Non-functioning Pituitary Adenoma

NCT02861716 2018-04-10

Intrathecal Dexmedetomidine Versus Fentanyl With Bupivacaine in Children Undergoing Major Abdominal Cancer Surgery

South Egypt Cancer Institute

Phase 2 Unknown
60 enrolled
Other neoplasm

Intrathecal Dexmedetomidine

NCT01687751 2015-05-25

Pilot Study Comparing Treatment With Dexmedetomidine to Midazolam for Symptom Control in Advanced Cancer Patients

Fraser Health

Phase 2 Withdrawn
Other

Death, Delirium, Dyspnea, Nausea, Neoplasms, Pain, Intractable

Data powered by HemOnc (CC BY 4.0) Colophon âš¡